Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Niloufer Khan, MD, MS

Advertisement

Articles by Niloufer Khan, MD, MS

Current Treatment of Peripheral T-cell Lymphoma

ByRobert Stuver, MD,Zachary D. Epstein-Peterson, MD,William T. Johnson, DO,Niloufer Khan, MD, MS,Natasha Lewis, MD,Alison J. Moskowitz, MD,Craig S. Sauter, MD,Steven Horwitz, MD
May 13th 2022

This review article written by Robert Stuver, MD, et al, reviews current and available treatments for peripheral T-cell lymphoma.

Advertisement

Latest Updated Articles

  • Current Treatment of Peripheral T-cell Lymphoma
    Current Treatment of Peripheral T-cell Lymphoma

    May 13th 2022



Advertisement
Advertisement

Trending on CancerNetwork

1

MASLD Raises Liver and Other Cancer Risks, Supporting Selective HCC Surveillance

2

Weighing Immunotherapy for Bridging and Downstaging Before HCC Transplant

3

What Separates a Next-Generation Liver Tumor Board From the Traditional Model?

4

BOT+BAL Yields Long-Term Survival in Patients With Refractory MSS mCRC

5

Training, Invasiveness, and Workload Behind Falling Prostate Brachytherapy Use

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us